Mouse cardiac tissue: Vehicle treated control vs. 15mg/kg doxorubicin
收藏官方服务:
资源简介:
Mouse cardiac tissue: Vehicle treated control vs. 15mg/kg doxorubicin
应用场景:
创建时间:
2010-08-06
相关数据集
The human amniotic fluid stem cell secretome counteracts doxorubicin-induced cardiotoxicity. Mus musculus
The anthracycline, doxorubicin (Dox), is widely used in oncology, but it may it may cause a cardiomyopathy which has dismal prognosis and cannot be effectively prevented. The secretome of multipotent
NIAID Data Ecosystem90
Targets of miR-212/132 in doxorubicin-induced cardiotoxicity
We overexpressed miR-212/132 by AAV9 in mouse model of doxorubicin-induced cardiotoxicity and wanted to identify myocardial targets of miR-212/132 in this model. AAV9-Control or AAV9-miR-212/132 was i
NIAID Data Ecosystem40
DataSheet1_I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway.pdf
Dilated cardiomyopathy (DCM) can lead to heart expansion and severe heart failure, but its specific pathogenesis is still elusive. In many cardiovascular diseases, I-κB kinase-ε (IKKε) has been recogn
NIAID Data Ecosystem30
Cardiotoxicity of Doxorubicin Treatment and Physical Activity: A Systematic Review
Abstract The present study investigated whether the practice of exercise has a protective effect against cardiac toxicity induced by doxorubicin (DOX). A systematic review of randomized clinical trial
Figshare2017-02-01 更新40
CircRNA expression patterns in human DOXCM and control heart tissues. CircRNA expression patterns in human DOXCM and control heart tissues
CircRNA profiling of 3 samples of human heart with doxorubicin-induced cardiomyopathy(DOXCM) and 3 healthy hearts Overall design: To screen the potentially involved circRNAs in doxorubicin-induced car
NIAID Data Ecosystem30



